Skin permeation enhancer compositions
US4568343A · kind A · utility
270Cited by
21References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 1984 |
| Grant date | Feb 4, 1986 |
| Priority date | — |
| Expiry date | Oct 9, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for enhancing the transdermal flux of a transdermally deliverable drug through intact skin is described in which the drug is delivered simultaneously with polyethylene glycol monolaurate. Preferred embodiments of transdermal therapeutic systems for delivering drug and polyethylene glycol monolaurate employ matrix containing drug at a concentration above saturation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.